Ayca Muftuler Løndalen

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial

Kjetil Boye, Alessandra Longhi, Tormod Kyrre Guren et al. · Cancer Immunology Immunotherapy · 2021 · 106 citations · Full text

Medicine, Oncology, Pharmacology +17

Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma

Trond Hagtvedt, Therese Seierstad, Kjersti V. Lund et al. · Acta Radiologica · 2014 · 48 citations

Medicine, Oncology, Radiology +17

18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma

Trond Velde Bogsrud, Ayca Muftuler Løndalen, Petter Brandal et al. · Clinical Nuclear Medicine · 2019 · 45 citations

Medicine, Oncology, Radiology +17

Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

Arne Kolstad, Tim Illidge, Nils Bolstad et al. · Blood Advances · 2020 · 44 citations · Full text

Medicine, Hematology, Oncology +14

Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment

Eirik Auning, Per Selnes, Ramunė Grambaitė et al. · Acta Psychiatrica Scandinavica · 2014 · 43 citations · Full text

Medicine, Neuroscience, Psychiatry +17